Crossref
Design and Virtual Screening of Dihydropyrimidinone and Chromene-Based Derivatives as Potential SARS-CoV-2 NSP16 Methyltransferase Inhibitors
Pharmacognosy Journal · 01.07.2026 · 18 (2) · 171-180
DOI: 10.5530/pj.2026.18.131 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmacognosy Journal, online erschienen am 01.07.2026. Verfasst von Dinar Adriaty und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Adriaty, D., Suwito, H., & Puspaningsih, N. N. T. (2026). Design and Virtual Screening of Dihydropyrimidinone and Chromene-Based Derivatives as Potential SARS-CoV-2 NSP16 Methyltransferase Inhibitors. Pharmacognosy Journal, 18(2), 171-180. https://doi.org/10.5530/pj.2026.18.131
Vancouver
Adriaty D, Suwito H, Puspaningsih NNT. Design and Virtual Screening of Dihydropyrimidinone and Chromene-Based Derivatives as Potential SARS-CoV-2 NSP16 Methyltransferase Inhibitors. Pharmacognosy Journal. 2026;18(2):171-180. doi:10.5530/pj.2026.18.131
BibTeX
@article{Adriaty2026,
author = {Adriaty, Dinar and Suwito, Hery and Puspaningsih, Ni Nyoman Tri},
title = {Design and Virtual Screening of Dihydropyrimidinone and Chromene-Based Derivatives as Potential SARS-CoV-2 NSP16 Methyltransferase Inhibitors},
journal = {Pharmacognosy Journal},
year = {2026},
volume = {18},
number = {2},
pages = {171--180},
doi = {10.5530/pj.2026.18.131}
}
EUVIMED